National Cancer Institute - NCI Division of Cancer Treatment and ...

program fosters collaborations within
the cancer research community and
works extensively with the pharmaceutical
and biotechnology industries as
well. CTEP also reaches out to patients
and their advocates to help establish
research priorities.
■ Developmental Therapeutics
Program (DTP)—serves as a vital
resource in discovering potential cancer
therapeutics and acquiring preclinical
development information. The program
provides research materials, including
Web-accessible data and tools, vialed
and plated compounds, tumor cells,
and research animals, and manufactures
new agents in bulk quantities for use in
investigational new drug (IND)–directed
studies. The program is playing a central
role in new collaborations with the NCI
Center for Cancer Research (CCR) to reinvigorate
the cancer drug development
pipeline, with the goal of significantly
shortening the amount of time it takes
to safely develop effective new treatments
for patients with cancer.
■ Radiation Research Program (RRP)—
supports clinical research by providing
expertise to investigators who perform
novel radiotherapy research, assisting
the radiotherapy research community
in establishing priorities for the future
direction of radiation research, providing
medically underserved communities
with access to radiotherapy, and
evaluating the effectiveness of radiation
research being conducted by NCI grantees.
RRP also coordinates its activities
with other radiation research programs
at NCI, NIH, other federal agencies, and
national and international research
organizations. Additionally, RRP serves
as a focal point for extramural investigators
concerned with clinically related
radiation research.
D I V I S I O N O F C A N C E R T R E A T M E N T A N D D I A G N O S I S ■ 5